跳至主要内容
临床试验/NCT04777812
NCT04777812已完成不适用

Pancreatitis - Microbiome As Predictor of Severity

University Medical Center Goettingen2 个研究点 分布在 1 个国家目标入组 424 人开始时间: 2020年2月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
424
试验地点
2
主要终点
Revised Atlanta classification I-III

研究概览

简要总结

This study is a multicentric prospective study initiated and coordinated from the University Medical Centre Goettingen. The study aims to evaluate the orointestinal microbiome as a potential biomarker for the course, severity and outcome of patients with acute pancreatitis.

详细描述

This prospective translational study aims to evaluate the orointestinal microbiome as a potential biomarker for the course, severity and outcome of patients with acute pancreatitis. From each patient one buccal and rectal swab is collected within 72 h after hospital admission. Microbial composition will be determined by 16S and metagenomics Oxford Nanopore Sequencing (ONT) and correlated with the revised Atlanta classification as the primary endpoint. Secondary endpoints are the correlation of microbiome signatures with the length of hospital stay, numbers of interventions and mortality. To this end, alpha and beta diversity of microbiota are determined and compared between mild, moderately severe and severe acute pancreatitis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with acute pancreatitis (2 out of 3 following diagnostic criteria: lipase >3x of upper limit, abdominal pain, and imaging modalities (computed tomography, magnetic resonance imaging or ultrasound).
  • < 72 hours after hospital admission.

排除标准

  • Pregnant women Patients < 18 years; Patients who are incapable of giving consent

结局指标

主要结局

Revised Atlanta classification I-III

时间窗: up to 8 weeks

Microbial composition (alpha and beta-diversity) will be correlated with the revised Atlanta classification.

次要结局

  • Length of hospital stay(up to 12 months)
  • Mortality(up to 12 months)
  • Numbers of interventions (surgical and endoscopical)(up to 12 months)

研究者

发起方
University Medical Center Goettingen
申办方类型
Other
责任方
Principal Investigator
主要研究者

Albrecht Neesse

Prof. Dr. Dr.

University Medical Center Goettingen

研究点 (2)

Loading locations...

相似试验

Pancreatitis - Microbiome As Predictor of Severity | 临床试验